DermaSensor None
DermaSensor aims to offer a solution to the lack of skin cancer evaluations by providing an affordable, handheld device that uses machine learning and spectroscopy to quickly and objectively evaluate skin lesions for potential cancer. Their mission is to save lives and reduce healthcare costs by enabling early detection of skin cancer. The device is designed to assist primary care providers in evaluating skin lesions for the risk of cancer in seconds.
Estimated Revenue:
$132,743.5 million
Headquarters:
Miami, Florida, United States
Employee Number:
11-50